By Phage Consultants
To get in touch with Phage Consultants, simply fill out the form below.
Subscribe to Supplier
Phage Consultants to warn ISBioTech of ‘crouching and hidden’ bacteriophage dangers
Gdansk, Poland: – Bacteriophage technology specialist contract research organization Phage Consultants will use the upcoming online ISBioTech Waterside conference to warn the bioprocess community of the dangers of ‘camouflaged’ phage contaminations in processes.
Phage Consultants founder and CEO Dr. Marcin Los is once again an invited speaker at the virtual event, delivering an online address Crouching T1, Hidden DE3 – how lysogeny, pseudolysogeny and hibernation may camouflage phages in the process.
Hidden contamination threats
Starting at 1320 EST on Tuesday November 17 as part of the conference’s Contaminant Control stream, the presentation will warn fermentation teams and production facility managers of the ability of bacteriophages to become hidden in bioprocesses through the processes of lysogeny, pseudolysogeny and hibernation, leading to unexpected and expensive contaminations.
Dr. Los will outline a range of techniques that can be used to recognize such camouflaged contaminations, prevent them and deal with them if they occur.
Reduced DE3 background Cell Bank Testing
PC will also use the event’s networking platforms to present its broader contamination control services and its unique offer of Cell Bank Testing with DE3-related background reduction. This uses newly-developed technology and carefully designed protocols to overcome one of the major problems in cell bank testing: the presence of the DE3 prophage causing false positive results in phage and prophage testing.
Phage Consultants testing can remove the DE3-related background with high precision and ensure reliable analysis of any bacterial strain, with or without the DE3 prophage.
About Phage Consultants
Phage Consultants is a contract research and manufacturing organization that specializes in bacteriophage detection, characterization and production.
Bacteriophages (phages) are viruses that infect bacteria. First discovered around 1915, phages played an important role in understanding viral biology, for example in elucidating viral reproduction in lytic and lysogenic cycles. They have been used for almost a century as alternatives to antibiotics and can have therapeutic effect against multi-drug-resistant strains of many bacteria.
Founded in Gdansk, Poland, in 2007, PC has become a world leader in using the power of bacteriophage technology in bioprocess infection and contamination control and assisting companies whose production is based on microbial activities in preventing bacteriophage contamination, along with bacterial, fungal and viral contaminations.
Phage Consultants is also a team specialist in the field of bacteriophage biology with specific expertise in phage activity in bioprocesses. The team provides unique assistance to pharmaceutical and biotech companies, offering a range of services from personal training to consulting and process optimization in phage growth limitation. The company also advises and assists clients in the development of new production facilities.
About ISBioTech 2020
The International Society for BioProcess Technology (ISBioTech) was established in 2010 to advance process and analytical techniques, making the latest bioprocess technology readily available to organizations developing and producing biopharmaceuticals worldwide.
Replacing the Society’s usual Fall Meeting due to the COVID-19 emergency, the ISBioTech Waterside™ conference is three-day virtual event opening November 16 and using online conferencing and networking platforms.
This innovation-focused meeting will once again feature three streams; this time looking at Cell Banking & Characterization, Contaminant Control and Raw Materials Science & Control.
ISBioTech Waterside is organized by International Society For Bioprocess Technology with more information available at: https://www.isbiotech.org/waterside2020
Click on Phage Detection for further information on PC capabilities.
Dr. Marcin Los, CEO, Phage Consultants